PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsGenistein
Genistein
Genistein is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target steroid hormone receptor ERR2, estrogen receptor beta, steroid hormone receptor ERR1, cystic fibrosis transmembrane conductance regulator, short transient receptor potential channel 5, and estrogen-related receptor gamma.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
92 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cardiovascular diseasesD002318HP_000162611114
Covid-19D000086382112
Post-acute covid-19 syndromeD000094024112
Irritable bowel syndromeD043183EFO_0000555K5811
OverweightD050177E66.311
Pelvic floor disordersD05995211
SepsisD018805HP_0100806A41.911
ToxemiaD01411511
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C502315
NeoplasmsD009369C80334
Non-small-cell lung carcinomaD002289222
Lung neoplasmsD008175HP_0100526C34.90222
Pancreatic neoplasmsD010190EFO_0003860C2522
LeukemiaD007938C95112
Lymphoid leukemiaD007945C91112
AdenocarcinomaD000230122
Non-hodgkin lymphomaD008228C85.9112
LymphomaD008223C85.9112
Show 47 more
Indications Phases 1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.933
Insulin resistanceD007333HP_000085522
Type 2 diabetes mellitusD003924EFO_0001360E1122
Diet therapyD00403511
Weight lossD015431HP_000182411
Blood pressureD001794EFO_000432511
Male breast neoplasmsD01856711
Disease progressionD01845011
Alzheimer diseaseD000544EFO_0000249F0311
Nutrition therapyD04462311
Show 17 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGenistein
INNgenistein
Description
Genistein is a 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a phytoestrogen, a plant metabolite, a geroprotector and a human urinary metabolite. It is a conjugate acid of a genistein(1-).
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12
Identifiers
PDB
CAS-ID446-72-0
RxCUI
ChEMBL IDCHEMBL44
ChEBI ID28088
PubChem CID5280961
DrugBankDB01645
UNII IDDH2M523P0H (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
ESR2
ESR2
ESRRB
ESRRB
Organism
Homo sapiens
Gene name
ESR2
Gene synonyms
ESTRB, NR3A2
NCBI Gene ID
Protein name
estrogen receptor beta
Protein synonyms
estrogen receptor beta 2, estrogen receptor beta 4, Nuclear receptor subfamily 3 group A member 2, oestrogen receptor beta
Uniprot ID
Mouse ortholog
Esr2 (13983)
estrogen receptor beta (O08537)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 30,686 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
5 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use